Fundz

Vivos Therapeutics, Inc. reported raising $50,000 in an initial SEC Form D filing, from an offering of $18 Million

PUBLIC · VVOSFeb 20, 2020$50K of $18M raised

Amount Raised

$50,000

$50,000 sold, per SEC Form D (first sale Feb 20, 2020)

Round Type

Seed

LittletonBiotechnologyHealth CareMedicalTherapeutics

Quick answer

Vivos Therapeutics raised $50,000 in a Seed round, dated February 20, 2020. Vivos Therapeutics is based in Littleton, Colorado, United States.

How much did Vivos Therapeutics raise?
Vivos Therapeutics raised $50,000 in a Seed round on February 20, 2020.
What does Vivos Therapeutics do?
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues..
Where is Vivos Therapeutics based and how big is it?
Vivos Therapeutics is based in Littleton, Colorado, United States. Fundz records about 63 employees.
Who are the decision-makers at Vivos Therapeutics?
Fundz holds 3 contacts at Vivos Therapeutics, including the Executive Vice President of Business Operations Integration. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Vivos Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Immuneering raised $20M on January 27, 2020.
  • Aethlon Medical raised $2.7M on January 24, 2020.
  • Damora Therapeutics, Inc. raised $79M on January 16, 2020.
  • Pliant Therapeutics raised $48M on January 9, 2020.
  • Vaxcyte, Inc. raised $110M on April 3, 2020.
  • Dyne Therapeutics raised an undisclosed amount on March 31, 2020.

Who to call at Vivos Therapeutics, and when

A new round usually means Vivos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vivos Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vivos Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vivos Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vivos Therapeutics

Location

7921 Southpark Plaza

Littleton, Colorado, United States

About

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in approximately 40,000 patients treated worldwide by more than 1,800 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using The Vivos Method.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vivos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsMike B., Executive Vice President of Business Op…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vivos Therapeutics's next move

See what Strategic adds

Vivos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.